Signature Diagnostics Selects Genedata's Computational Solution
News Nov 01, 2005
Genedata AG, have licensed their Genedata Expressionist® software solution to Signature Diagnostics AG. The diagnostics company will use Genedata's software to help them identify unique gene expression profiles found in colorectal cancer (CRC) patients.
"We needed a scalable, regulatory-compliant solution to accommodate our high-throughput diagnostic clinical discovery efforts", says Professor André Rosenthal, CEO, Signature Diagnostics AG.
The software will be used to process and analyze Affymetrix GeneChip data from thousands of CRC patients receiving treatment at dozens of specialized oncology clinics. Using powerful proprietary algorithms, the goal is to identify unique gene expression signatures that predict the risk of recurrence and response to therapy of individual patients.
"Genedata offers the only industrial-scale solution to automate the entire workflow from sample management to statistical analysis and biological interpretation."
"Signature Diagnostics brings tremendous expertise in molecular diagnostics to the challenge of cancer biomarker discovery", says Dr Othmar Pfannes, CTO of Genedata AG. Genedata Expressionist® facilitates tight integration between data, analysis and biomedical knowledge.
Companies scaling up their expression analysis operations quickly encounter the need for automation and standardization. "This is where a platform like Expressionist comes into its own."
3-D Printed Sugar Scaffolds Offer Sweet Solution for Tissue EngineeringNews
University of Illinois engineers built a 3-D printer that offers a sweet solution to making detailed structures that commercial 3-D printers can’t: Rather than a layer-upon-layer solid shell, it produces a delicate network of thin ribbons of hardened isomalt, the type of sugar alcohol used to make throat lozenges.READ MORE
3D Printer Developed That Can Create Complex Biological TissuesNews
A UCLA bioengineer has developed a technique that uses a specially adapted 3D printer to build therapeutic biomaterials from multiple materials. The advance could be a step toward on-demand printing of complex artificial tissues for use in transplants and other surgeries.READ MORE
Microfluidic Device Captures Extracellular Vesicles Shed by Brain TumorsNews
Because needle biopsies of brain tumors are invasive and difficult, bioengineers supported by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) have developed micro-technologies that capture extracellular vesicles (EVs) released by the tumor.READ MORE